Miracle prostate cancer drug not so miraculous?
The Mayo clinic reported over the weekend in its news section that two men with late-stage prostate cancer were successfully treated with a monoclonal antibody treatment (one of the most promising areas of research for cancer drugs) developed by Medarex Inc. Shares increased by 20% on Monday. An article by the AP pointed out at [...]
Read More